Document Detail


Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma.
MedLine Citation:
PMID:  1516016     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Infants (age 0-11 months) with disseminated neuroblastoma are known to have a better prognosis than older children with the disease, but there is little information regarding factors that influence the outcome of the disease in these patients. METHODS: The authors report a series of 110 infants with disseminated neuroblastoma with disease diagnosed between March 1976 and February 1991 in 21 institutions participating in the Italian Cooperative Group on Neuroblastoma (ICGNB). Of the 110 infants, 34 had Stage IV disease, and 76 had Stage IV-S disease. RESULTS: The 5-year survival probability was 77% for all patients, 71% for those with Stage IV disease, and 81% for those with Stage IV-S disease. Of the 34 infants with Stage IV disease, the 9 who were 5 months or younger at the time of disease diagnosis are all alive (1 with active disease) at 7-143 months after diagnosis, whereas of the 25 infants who were 6-11 months of age at the time of disease diagnosis, 10 have died. Of the 76 infants with Stage IV-S disease, 12/64 who were 5 months of age or younger at the time of disease diagnosis died (mostly of massive hepatomegaly); 9 of these deaths occurred in infants with disease diagnosed before they were 2 months old, whereas 1 death occurred in the 12 infants with disease diagnosed when they were 6-11 months old. Four infants with Stage IV-S disease achieved complete disease remission and subsequently had relapse of disease. High levels of serum LDH and low urinary excretion of vanillylmandelic acid were associated with worse prognosis. CONCLUSIONS: The authors suggest that infants older than 6 months of age who have Stage IV disease require aggressive therapy. For infants with disease diagnosed before they are 2 months old, Stage IV-S disease may have a worse prognosis than Stage IV disease.
Authors:
B De Bernardi; C Pianca; L Boni; M Brisigotti; M Carli; S Bagnulo; P Corciulo; A Mancini; C De Laurentis; M T Di Tullio
Related Documents :
6821866 - Primary ewing's sarcoma of the ribs. a report from the intergroup ewing's sarcoma study.
9113196 - Alzheimer's disease: transiently developing dendritic changes in pyramidal cells of sec...
15697406 - Complexity, fractals, disease time, and cancer.
23946756 - Mycobacterium intracellulare pulmonary disease with endobronchial caseation in a patien...
3323456 - Hodgkin's disease of the thymus: a rare mediastinal cystic mass.
17785866 - Tgf-beta 1 variants in chronic beryllium disease and sarcoidosis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cancer     Volume:  70     ISSN:  0008-543X     ISO Abbreviation:  Cancer     Publication Date:  1992 Sep 
Date Detail:
Created Date:  1992-10-08     Completed Date:  1992-10-08     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  0374236     Medline TA:  Cancer     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1625-33     Citation Subset:  AIM; IM    
Affiliation:
Department of Hematology-Oncology, Giannina Gaslini Children's Hospital, Genova, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Female
Humans
Infant
Male
Neoplasm Staging
Neuroblastoma / mortality*,  pathology*,  secondary,  therapy
Prognosis
Retrospective Studies
Survival Analysis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect.
Next Document:  Tinea corporis confined to irradiated skin. Radiation port dermatophytosis.